Millrace Asset Group’s HTG Molecular Diagnostics HTGM Stock Holding History
Bought
Maintained
Sold
Other funds holding HTGM
Millrace Asset Group's HTGM Position: Q4 2018 in Review
Millrace Asset Group sold out of HTG Molecular Diagnostics (HTGM) in Q4 2018, closing a stake of 1,111 shares — an estimated $1.01M sold.
Millrace Asset Group first reported a position in HTGM in Q3 2018 and held it in 1 quarter. The position peaked at $1.01M in Q3 2018. 48 funds tracked by Wall St. Rank hold HTGM as of Q4 2018.
- Millrace Asset Group reported no remaining HTG Molecular Diagnostics position as of Q4 2018 after selling out during the quarter.
- Millrace Asset Group sold 1,111 HTG Molecular Diagnostics shares in Q4 2018, an estimated $1.01M.
- Millrace Asset Group first reported a position in HTG Molecular Diagnostics in Q3 2018 and held it in 1 quarter.
- Millrace Asset Group's HTG Molecular Diagnostics position peaked at $1.01M in Q3 2018.
- 48 funds tracked by Wall St. Rank held HTG Molecular Diagnostics as of Q4 2018.
Based on Millrace Asset Group's 13F filing for Q4 2018, filed 13 Feb 2019.